Johnson & Johnson (NYSE: JNJ) didn't have an exceptional 2024; in fact, it was one of the worst-performing stocks on the vaunted, 30-company Dow Jones Industrial Average that year. Yet, if the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback